BEIJING, Jan. 31, 2011 /PRNewswire-Asia-FirstCall/ — China
Medical Technologies, Inc. (the “Company”) (Nasdaq:
CMED), a leading China-based advanced in-vitro diagnostic
(“IVD”) company, today announced that it will report its unaudited
financial results for the third fiscal quarter ended December 31,
2010 before the U.S. market opens on February 18, 2011. The
Company’s 2010 fiscal year ends on March 31, 2011.
The Company’s senior management will host an earnings conference
call at 8:00 a.m. U.S. Eastern Time on February 18, 2011 (9:00 p.m.
Beijing/Hong Kong time on February 18, 2011).
Conference CallThe dial-in details for the live conference
call are as follows:-
U.S. Toll Free Number 1-866-783-2141-
International Dial-in Number 1-857-350-1600Passcode: CMEDCALLA live
webcast of the conference call will be available on http://ir.chinameditech.com.
A replay of this webcast will be available for one month on
A telephone replay of the call will be available after the
conclusion of the conference call through 10:00 a.m. U.S. Eastern
Time on February 19, 2011. The dial-in details for the replay
are as follows:
U.S. Toll Free Number 1-888-286-8010-
International Dial-in Number 1-617-801-6888Passcode:
46276526About China Medical Technologies, Inc.China
Medical Technologies, Inc. is a leading China-based advanced IVD
company using molecular diagnostic technologies including
Fluorescent in situ Hybridization (FISH) and Surface Plasmon
Resonance (SPR) and an immunodiagnostic technology, Enhanced
Chemiluminescence Immunoassay (ECLIA), to develop, manufacture and
distribute diagnostic products used for the detection of various
cancers, diseases and disorders as well as companion diagnostic
tests for targeted cancer drugs. The Company generates all of its